Drug recall · April 16, 2025
Haloperidol Decanoate Injection 100mg/mL recall
Why: Lack of Assurance of Sterility: Media fill with bacterial contamination
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka, India, Manufactured for: BluePoint Laboratories NDC 68001-581-41 (individual carton) and NDC 68001-581-48 (5x1 mL cartons)
- Lots / codes
NDC 68001-581-41; A240482A, exp. date 08/2026; NDC 68001-581-48; A240482B, exp. date 08/2026
- Quantity
- 23,960 vials
- Company
- Somerset Therapeutics Private Limited, Bengaluru, N/A
- Distribution
- U.S. Nationwide
- Initiated
- March 21, 2025 · Voluntary: Firm initiated
- Classified
- April 8, 2025
- Reported
- April 16, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Haloperidol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.